Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)

Cardwell K, Harrington P, Teljeur C, Swanton D, McLoughlin C, Ryan M
Record ID 32018005157
English
Authors' objectives: The aim of this rapid Health Technology Assessment was to inform a decision on expanding the influenza vaccination programme in Ireland to include reimbursement of standard quadrivalent influenza vaccines (QIVs) for those aged 50 to 64 years old in the general population (that is, those not at increased risk of sever disease from influenza).
Details
Project Status: Completed
URL for project: https://www.hiqa.ie/reports-and-publications/health-technology-assessment/rapid-health-technology-assessment-extension
URL for protocol: https://www.hiqa.ie/sites/default/files/2023-08/Rapid-HTA-50-64-years-protocol.pdf
Year Published: 2023
URL for published report: https://www.hiqa.ie/sites/default/files/2023-08/Rapid%20HTA-of-flu-vaccine-50-64-general-population.pdf
Requestor: Department of Health, Ireland
English language abstract: An English language summary is available
Publication Type: Mini HTA
Country: Ireland
MeSH Terms
  • Influenza Vaccines
  • Influenza, Human
  • Mass Vaccination
  • Vaccination Coverage
  • Adult
Keywords
  • Influenza
  • Vaccination
  • Cost analysis
Contact
Organisation Name: Health Information and Quality Authority (HIQA)
Contact Address: Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name: info@hiqa.ie
Contact Email: info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.